⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer

Arian Lundberg Meng Zhang Rahul Aggarwal Haolong Li Li Zhang Adam Foye Martin Sjöström Jonathan Chou Kevin Chang Thaidy Moreno-Rodriguez Raunak Shrestha Avi Baskin Xiaolin Zhu Alana S. Weinstein Noah Younger Joshi J. Alumkal Tomasz M. Beer Kim N.Christopher P. Evans Martin Gleave Primo N. Lara Rob E. Reiter Matthew B. Rettig Owen N. Witte Alexander W. Wyatt Felix Y. Feng Eric J. Small David A. Quigley

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Gene expression level of CHD7 among the mCRPC tumors of Beltran et al. cohort

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lundberg et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db6435875233de https://doi.org/10.1158/0008-5472.27028174.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 6. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
2Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
3Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
4Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
5Supplementary Figure 8. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024

More related papers

Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
Supplementary Figure 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024